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ABSTRACT
Background: Allergen immunotherapy is effective in allergic individuals however efforts are being made to
improve its safety, convenience, and efficacy. It has recently been demonstrated that allergen-linked im-
munostimulatory DNA (ISS) is effective in stimulating an allergen-specific Th1 response with decreased aller-
genicity. The objective of this study is to investigate whether ISS linked to purified ragweed allergen Amb-a-1
(AIC) can inhibit local allergen-specific Th2 and induce allergen-specific Th1 responses in explanted nasal mu-
cosa of ragweed-sensitive subjects. In addition, we set out to determine whether AIC is more effective com-
pared to stimulation with unlinked Amb a 1 and ISS.
Methods: Tissue from ragweed-sensitive patients (n = 12) was cultured with whole ragweed allergen (RW),
Amb-a-1, AIC, Amb-a-1 and ISS (unlinked), or tetanus toxoid (TT) for 24 hours. IL-4, -5, -13, TNF-α and IFN-γ
mRNA-positive cells were visualized by in situ hybridization and T cells, B cells and neutrophils were enumer-
ated using immunocytochemistry.
Results: RW or Amb-a-1 increased the number of IL-4, IL-5, and IL-13 mRNA+ cells in the tissue compared to
medium alone. AIC had similar cytokine mRNA reactivity as control tissue. AIC and TT increased IFNγ-mRNA
expression. Unlinked Amb-a-1 and ISS showed similar effects to AIC, however this response was weaker. The
number of TNF mRNA+ cells, T cells, B cells and neutrophils remained unchanged.
Conclusions: AIC is effective in stimulating a local allergen-specific Th1- and abolishing Th2-cytokine mRNA
reactivity in the nose and may be considered as a strong candidate for an improved approach to immunother-
apy in ragweed-sensitive individuals.
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ABBREVIATIONS
Amb a 1, short, purified ragweed allergen; AIC, Amb a 1-immunostimulatory phosphorothioate oligonucleotide
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interleukin-; ISH, in situ hybridization; ISS, immunostimulatory DNA sequences; RW, ragweed; TT, tetanus
toxoid.
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INTRODUCTION
Immunotherapy by injection of aqueous allergen ex-
tracts is currently used as a form of treatment for al-
lergic diseases. This form of therapy is thought to
promote Th1 immunity in allergic patients leading to
the alleviation of symptoms that result from allergen-
specific Th2 responses. Although generally effective,
allergen immunotherapy is associated with a number
of disadvantages such as the inconvenience of fre-
quent dosing, its long duration of therapy, as well as
the risk of anaphylaxis.1,2 As a result, many modifica-
tions of allergen immunotherapy have been at-
tempted to improve its safety and effectiveness, in-
cluding the use of allergen extracts. Although chemi-
cal modification of allergens can reduce their aller-
genicity, this strategy can also reduce the allergen’s
potential for stimulating the immune system, render-
ing them unsuitable for immunotherapy.3,4
Recently, immunostimulatory DNA sequences
(ISS) containing CpG motifs have become attractive
candidates as they have been shown to act as strong
Th1 response-inducing adjuvants.5 These vaccines
target TLR9 on plasmacytoid dendritic cells (pDC)
with subsequent activation of the innate immune sys-
tem.6 These immune responses favor the develop-
ment of a Th1 type response. Using a mouse model of
eosinophilic airway inflammation, Broide and col-
leagues have shown that administration of ISS-ODN
to mice inhibits both airway hyperresponsiveness and
airway eosinophilia by exerting significant inhibitory
effects on IL-5, GM-CSF and IL-13 cytokine produc-
tion whilst inducing the expression of IFN-γ.7 Direct
conjugation of CpG to allergen reduced the dose of
CpG required for this response, and has been shown
to be effective at modifying Th2 responses in a vari-
ety of species.6
One compound that has received a lot of attention
recently is Amb a 1-immunostimulatory-phospho-
rothioate oligonucleaotide conjugate (AIC). Conjuga-
tion of ISS is on the major short ragweed allergen
Amb-a -1, and Tighe and colleagues have demon-
strated enhanced immunogenicity and reduced aller-
genicity in a mouse model of allergic disease and in-
duction of IFN-γ dependent IgG2α and IgG2β anti-
body production.6 Although they have further shown
unlinked Amb-a-1 with ISS-ODN also induces a Th1
response in mice, this response was significantly
weaker than that induced with the allergen-linked-ISS
conjugate.6 Importantly, AIC has also been reported
to be less reactive with human IgE anti-Amb a 1 anti-
bodies and to require 30-fold more conjugate than
Amb a 1 alone to release the same amount of hista-
mine from basophils of ragweed-sensitive patients.8
More recently, the effect of AIC was investigated on
human cellular immune function where AIC was
shown to promote Th1- and down-regulate ragweed-
specific Th2-cytokine expression in PBMCs from
ragweed-sensitized individuals.9,10 We have shown in
a clinical setting, that short-course immunotherapy
with AIC can modify the response of nasal mucosa to
allergen challenge in rhinitis patients.11 This modifi-
cation was not immediate but was observed 4-5
months after completion of immunotherapy and after
seasonal ragweed-pollen exposure. In that study,
clinical efficacy was observed in the second ragweed
season and without any additional AIC immuniza-
tions.
In this follow-on study we set out to investigate the
effect of Amb a 1-linked-ISS (AIC) on ex vivo ragweed-
induced allergic responses in explanted nasal tissue
from ragweed-sensitive individuals to investigate the
mechanisms which may be involved in AIC’s ability
to deviate the nasal immune response from Th2- to
Th1-phenotype. The unique nature of our explant sys-
tem allows us to examine the effect of AIC on local,
allergen-driven immune responses in the nose and to
examine the contribution of local inflammatory cells
in this model. In addition, we set out to determine
whether AIC is more effective at modulating the
allergen-specific local Th1Th2 responses than stimu-
lation with unlinked Amb-a-1 and ISS.
METHODS
PATIENT SELECTION
Twelve (n = 12) patients with allergic rhinitis were re-
cruited from the nasal clinic at the Nôtre Dame Hos-
pital in Montreal, Canada. Hospital ethics committee
approval was obtained, and all volunteers gave a writ-
ten informed consent before commencement of the
study. All experiments were carried out in accor-
dance with the principles embodied in the Declara-
tion of Helsinki of 1995. Inclusion criteria included a
history of seasonal rhinitis for at least 2 years prior to
the study and a positive skin prick test response (>5
mm wheal) to ragweed extract. Patients were ex-
cluded if they had perennial allergies, had previously
received immunotherapy, or were taking oral anti-
inflammatory medication. Additional exclusion crite-
ria included hypogammaglobulinemia, a history of
cystic fibrosis, bronchiectasis, immotile cilia syn-
drome, systemic granulomatous disease, tobacco use,
cocaine use, or immunodeficiency. Wherever neces-
sary, antibiotics were withheld for a few weeks before
the study.
AIC was prepared by linking purified Amb a 1 with
1018 ISS (sequence: 5’-TGACTGTGAACGTTCGAGA
TGA-3’). Cross-linking was done with the heterobi-
functional linker sulfosuccinimidyl-4-(N-maleimido-
methyl) cyclohexane-1-carboxylate, which creates
stable amide and thioether bonds between the ISS oli-
gonucleotide and the Amb a 1. The average molar ra-
tio of Amb a 1 to 1018 ISS is 1 : 4. A more detailed de-
scription of AIC production and characterization has
been previously published.6
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TISSUE CULTURE
Nasal mucosal tissue was resected from patients un-
dergoing sinus surgery, who had given informed con-
sent prior to surgery. The tissue was obtained from
the inferior turbinate of ragweed-sensitive individuals
with seasonal allergic rhinitis, outside the ragweed
season. Serial sections of tissue were placed on 0.4-
μm well inserts (Millipore, Bedford, MA, USA) in 2
ml of defined medium and cultured with a) whole rag-
weed allergen (RW; 50 μgml), b) Amb a 1 (20 μg
ml), c) Amb a 1-linked-ISS (AIC, 5μgml), d) Amb-a-1
and ISS (unlinked, 20 μgml), or e) tetanus toxoid
(TT; 0.5 Limes flocculation [Lf]ml). Cultures were
incubated for 24 hours in 5% CO295% air. After this
period, tissue was fixed in 4% paraformaldehyde,
washed 3 times in 15% sucrosePBS and blocked in
optimal cutting temperature (OCT) medium by snap
freezing in isopentane cooled in liquid nitrogen.
IMMUNOCYTOCHEMISTRY
Immunocytochemistry using the alkaline phos-
phatase anti-alkaline phospatase (APAAP) technique
was performed on cryostat sections of nasal biopsies
as previously described.12 Anti-human CD3, CD4,
elastase and CD20 monoclonal antibodies (DAKO,
Mississauga, Ontario, Canada) were used to pheno-
type T cells, neutrophils, and B cells respectively.
Fast Red TR (Sigma-Aldrich, St. Louis, MO, USA)
was the chromogen used to develop the reaction,
therefore positive cells were identified as red under
light microscopy. Negative control experiments were
performed by replacing the primary Ab with an
isotype-matched control.
IN SITU HYBRIDIZATION
IL-4, IL-5, IL-13, TNF-α and IFN-γ mRNA-positive
cells were enumerated using in situ hybridization.
For Figure 1, radioactive in situ hybridization with
35S-labelled IL-4, IL-5, TNF, and IFN-γ cRNA probes
was performed as previously described.13 Briefly, sec-
tions were permeabilized with proteinase K (1 μg
ml) and Triton X-100. Prehybridization was per-
formed in 50% formamide (Sigma) in 2 X SSC solution
for 15 minutes at 37℃. Hybridization was performed
overnight with 35S-labelled antisense (complemen-
tary) and sense probes (identical to mRNA) in a hu-
mid chamber at 42℃. Post-hybridization washes of
decreasing concentrations of SSC solution (4 X to 0.1
X SS) were conducted at 42℃. Non-specific binding
was removed by washing in standard saline citrate,
again at 42℃. Excess and unbound RNA probe was
destroyed with RNase A (20 μgml). Slides were
dipped in LM-2 emulsion (Amersham, Oakville, Can-
ada), stored at 4℃ and exposed 11-15 days later. Au-
toradiographs were developed in Kodak D-19 solution
(Eastman Kodak, Toronto, Canada) and counter-
stained with Gill II Haematoxylin. Positive signals
were identified as a collection of silver grains overly-
ing the cells (illustrated in Fig.2).
In separate experiments we looked at the effect of
AIC or Amb-a-1 and ISS (unlinked) on Amb a 1-
induced Th2-cytokine mRNA reactivity (Fig.3, n =
12). Here we used digoxigenin (Dig)-labelled in situ
hybridization using digoxigenin-11-UTP labelled IL-4,
IL-5, IL-13 and IFN-γ mRNA riboprobes as previously
described.14 Color development in Dig-labeled in situ
hybridization was achieved by adding a freshly pre-
pared substrate solution consisting of 0.175 mg
X-phosphate-5-bromo-4-chloro-3-indoly phosphate
(BCIP) and 0.37 mg nitroblue tetrazolium (NBT) salt
per milliliter of equalization buffer to the slides (for
20-40 minutes at room temperature). Slides were
transferred to TBS and washed in tap water, and
counter-stained with hematoxylin for 5 seconds. Posi-
tive signals were identified by a purple stain on the
cells under light microscopy. Negative control experi-
ments using sense probes and RNase treatment be-
fore antisense probe applications were performed to
confirm probe specificity.
QUANTIFICATION
Using an Olympus light microscope (Carson Group,
Markam, Ontario, Canada) at X 200 magnification
with an eyepiece graticule of 0.202 mm2, slides were
analyzed for positive signal in a blinded fashion by
two independent examiners. Number of positive cells
were counted and expressed as the mean number of
cells per field.
STATISTICAL ANALYSIS
Inter-observer variance was examined by repeated
measurements of (n = 3) of 5 samples. Intra-observer
variance was tested by comparing the measurements
of 10 different non-overlapping fields performed by
two different observers. The intra-observer coefficient
of variation was less than 5% for the counting in differ-
ent samples measured 3 times. The intra-observer
correlation co-efficient was more than 0.95 (p <
0.0001) for the counting of positive cells. The individ-
ual results were expressed as the mean number of
positive cells per field ± SEM. The number of
immuno-reactive cells within each group were com-
pared using an ANOVA test, with a Dunnett’s correc-
tion. Probability values of less than 0.05 were consid-
ered statistically significant.
RESULTS
Th1 AND Th2 CYTOKINE mRNA EXPRESSION
To investigate the effect of AIC on the local Th1- and
Th2-mRNA cytokine reactivity in the nasal explant of
ragweed-sensitized patients (n = 12), tissue was cul-
tured with a) whole ragweed extract (RW), b) major
ragweed allergen (Amb a 1), c) Amb a 1-linked-ISS
(AIC), or d) tetanus toxoid (TT), a potent Th1-
inducer (Fig. 1). In the control, unstimulated nasal
explants, we detected constitutive IL-4, IL-5, TNF-α
Tulic MK et al.
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Fig. 1 The efect of AIC on alergen-induced cytokine mRNA expression. The number of IL-4 (A) , IL-5 (B) , TNF (C) and IFN-
γ(D)mRNA positive cels in explanted nasal tissue (n = 12) folowing incubation in a) medium alone (control) , b) whole ragweed 
alergen (RW, 50 μg/ml), c) Amb a 1 (20 μg/ml), d) Amb a 1-linked-ISS (AIC, 5 μg/ml), or e) tetanus toxoid (TT, 0.5 Lf/ml) for 24 
hrs. Cytokine mRNA immunoreactivity was assessed using radiolabeled 35S riboprobes.*P < 0.05,**P < 0.01 and ***P < 0.001 
versus control. #P < 0.05, ##P < 0.01 and ###P < 0.001 versus RW or Amb a 1 alergens.
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and IFNγ mRNA+ cells in the tissue. Incubation with
RW or Amb a 1 allergens significantly increased IL-4
(P < 0.001) (Fig. 1A) and IL-5 mRNA (P < 0.01) (Fig.
1B) expression with no change in IFN-γ mRNA reac-
tivity (Fig. 1D). A trend for greater IL-4 and IL-5
mRNA expression was seen in explants stimulated
with whole ragweed compared to Amb a 1 allergen
however this did not reach significance (P = 0.062).
AIC failed to increase IL-4 or IL-5 mRNA however
produced a significant increase in IFN-γ mRNA ex-
pression compared to control cultures (P < 0.01) and
those stimulated with allergen (Amb a 1) (P < 0.01)
or allergen extract (RW) (P < 0.01) (Fig. 1D). The in-
crease in IFNγ mRNA was similar to that seen follow-
ing stimulation with TT. TT produced no effect on IL-
4 or IL-5 mRNA expression (Fig. 1A, B). Although
there was a trend for increases in TNF mRNA in tis-
sue cultured with RW or Amb a 1 (P = 0.066) and de-
creases following incubation with AIC (P = 0.071),
these changes were not statistically significant
(Fig. 1C). Figure 2 are representative examples of in
situ hybridization with 35S-radiolabeled cRNA probes
directed against IL-5 mRNA or IFNγ mRNA in nasal
explanted mucosa stimulated with ragweed allergen
(50 μgml) in the absence or presence of AIC.
In the second set of experiments (n = 12) we set
out to determine whether AIC was more effective at
modulating the local Th1- and Th2-immune response
than both Amb a 1 and ISS added together (un-
linked). Here we used digoxigenin-labeled ribo-
Allergen-linked ISS in Nasal Explants
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Fig. 2 AIC-induced inhibition of Th2- and increase in Th1-cytokine mRNA expression. Representative examples of in situ hy-
bridization with 35S-radiolabeled cRNA probes directed against IL-5 mRNA (top rows) or IFNγ mRNA (botom rows) in nasal ex-
planted mucosa stimulated with ragweed alergen (50 μg/ml) in the absence (A and C) or presence of AIC (5 μg/ml) (B and D). 
Positive mRNA signal was identified as silver grains over the cels. Magnification X 100.
A
C D
B
probes to look at the local expression of IL-4, IL-5, IL-
13, and IFN-γ mRNA positive cells (Fig. 3). In addi-
tion to IL-4, IL-5 and IFN-γ we also detected constitu-
tive expression of IL-13 mRNA in the nasal tissue
(Fig. 3C). These cells were located throughout the
sub-mucosa. Ex vivo challenge with RW or Amb a 1
allergens induced significant increases in local IL-4,
IL-5 and IL-13 mRNA but not when incubated with
AIC. AIC induced a large increase in IFN-γ mRNA ex-
pression compared to control or allergen-stimulated
cultures (Fig. 3D). Unlinked Amb a 1 and ISS pro-
duced similar results to AIC however both of its ef-
fects on Th1- and Th2- cytokine mRNA production
were less effective (Fig. 3). The presence of exoge-
nous Amb a 1 allergen in cultures had no effect on
the ability of AIC to down-regulate local IL-4, IL-5 and
IL-13 mRNA expression (Fig. 3A-C) or to up-regulate
local IFN-γ mRNA (Fig. 3D). We found a strong posi-
tive correlation between IgG anti-Amb a 1 and IFNγ
mRNA (r = 0.838, P = 0.002) as well as a strong nega-
tive correlation between IgG anti-Amb a 1 and IL-4
mRNA (r = -0.742, P = 0.001) or IL-5 mRNA (r =
-0.788, P = 0.001) or IL-13 mRNA (r = -0.811, P =
0.002).
INFLAMMATORY CELL PROFILE
CD3+ pan T cells (48.2 ± 5 cellsfield), CD4+ T cells
(32.8 ± 2 cellsfield), CD20+ B cells (25.5 ± 1 cells
field) and elastase+ neutrophils (25.3 ± 2 cellsfield)
were localized in unstimulated nasal explanted tissue.
There was no significant difference in the local num-
ber of inflammatory cells following incubation with
either allergens alone, AIC or unlinked Amb a 1 and
ISS (data not shown).
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Fig. 3 The efect of alergen-linked-ISS versus addition of alergen with ISS in cultures on cytokine mRNA expression. The 
number of IL-4 (A) , IL-5 (B) , IL-13 (C) and IFN-γ(D)mRNA positive cels in explanted nasal tissue (n = 12) folowing incubation in 
a) medium alone (control) , b) whole ragweed alergen (RW, 50μg/ml) , c) Amb a 1 (20μg/ml) , d) Amb a 1-linked-ISS (AIC, 
5μg/ml), e) Amb a 1 + ISS (unlinked, 5μg/ml), or f) Amb a 1+ AIC for 24 hrs. Cytokine mRNA immunoreactivity was assessed us-
ing digoxigenin labeled riboprobes. *P < 0.05, **P < 0.01 and ***P < 0.001 versus control. #P < 0.05, ##P < 0.01 and ###P < 0.001 
versus RW or Amb a 1 alergens.
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DISCUSSION
In this study we demonstrated that administration of
Amb a 1-linked-ISS (AIC) inhibited the local allergen-
driven Th2 immune responses and promoted Th1 cy-
tokine expression in the explanted nasal mucosa of
ragweed-sensitized patients. This was demonstrated
by reduced expression of local tissue IL-4, IL-5 and
IL-13 mRNA and increased expression of IFN-γ
mRNA. A similar response was observed following
culture with unlinked Amb a 1 and ISS, however this
effect was weaker. These observations are consistent
with our previous work showing short-course immu-
notherapy with AIC effectively promoted Th1- and
down-regulated Th2-cytokine production in the nasal
biopsies of ragweed-sensitive patients following aller-
gen challenge.11 The lack of AIC effect on inflamma-
tory cell number suggests its lack of effect on local
cellular proliferation and is also consistent with our
previous findings in the nasal mucosa following incu-
bation with ragweed allergen.9
The proposed immunological mechanisms by
which specific immunotherapy is effective include
switching of allergen-induced Th2-immune responses
towards Th1 response, induction of tolerance, induc-
tion of protective immunoglobulin responses (de-
crease of allergen-specific IgE and increases in IgG
antibodies, mainly IgG4) and induction of regulatory
cells (reviewed in15). In our forerunner separate clini-
cal study, we have shown AIC immunotherapy to ef-
Allergen-linked ISS in Nasal Explants
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fectively increase protective IgG anti-Amb-a-1 anti-
body responses in ragweed-sensitive patients and to
effectively drive the immune responses away from
Th2 phenotype.11 In this study we provide novel evi-
dence for AIC directly affecting the local Th1Th2 cy-
tokine milieu in the nasal tissue without relying on
systemic recruitment of inflammatory cells to the site
of inflammation. Recent evidence from our group
suggests that these responses may be, at least in part,
modulated by the resident nasal Treg cells.16 In that
study we used the same patients as described here
and have shown AIC immunotherapy to significantly
increase the number of infiltrating CD4+CD25+ cells
into the nasal mucosa of allergic patients post-
seasonal ragweed-pollen exposure.16 Furthermore, in
that study a strong trend towards increased IL-10 im-
munoreactivity was observed, the source of which is
likely to be CD4+CD25+ Treg cells. Although we did
not perform IFNγ +CD4+CD25+ triple immunostain-
ing, T cells are also the most likely source of AIC-
induced IFNγ mRNA production as IFNγ staining was
localized predominantly to small mononuclear cells.
Furthermore, we know that CpG-induced activation
of TLR9 stimulates IFN-γ production from T cells via
indirect activation of pDC production of IL-12 and
IFN-α.17 It is interesting to note that following cell
stimulation with CpG DNA, TLR9 and the DNA are
found in the same endocytic vesicles,18 suggesting
that CpG modification of AIC may directly facilitate
increased uptake of this antigen into the cell. This
would allow activation of the same antigen presenting
cells to present Amb a 1 to T cells in a Th1 biasing
context induced by the CpG motifs.
Co-culture of Amb a 1 with ISS-ODN also induced a
Th1 response in nasal tissue, however it was weaker
than that induced with the corresponding ISS-
conjugate. Tighe and colleagues6 have similarly
shown that co-injection of Amb a 1 with ISS-ODN in
mice induced a weak Th1 response, albeit much
lower than that seen with AIC conjugate. This was
demonstrated by a lower IgG2α titer, and a signifi-
cantly lower level of IFN-γ secreted by T cells in mice
co-injected with a mixture of Amb a 1 and ISS.6 Ad-
ministration of Amb a 1 with ISS may result in the in
vivo dissociation of the ISS from the antigen, result-
ing in reduced efficiency. Chemical conjugation of
ISS to allergen on the other hand, confers allergen
properties that make it an optimal candidate for im-
munotherapy such as the induction of a rapid and sig-
nificant allergen-specific IFN-γ release as well as the
IgG antibody formation with injections of low doses
of allergen. These findings indicate that conjugation
of ISS to antigens may be necessary for successful in-
duction of immune responses to weak or very low
doses of antigens. The reason for this may be that ISS
and allergen need to be delivered to the same
antigen-presenting cell inducing a Th1-biasing mi-
croenvironment as mentioned above.6 The reduction
in CpG dose will also reduce the risk of potential ad-
verse effects of CpG administration, such as theoreti-
cal risks of induction of auto-immune disease or in-
flammatory responses.6,17,19
The results of this study demonstrate the effective-
ness of allergen-linked immunostimulatory DNA in
directly stimulating a local, Th1 response and de-
creasing an allergen-specific Th2 response, without
any significant effect on local cellular inflammation.
Although we have previously described the effective-
ness and safety of AIC immunotherapy in these same
patients,11 here we demonstrate for the first time that
AIC is capable of modifying local immune responses
in the nose and therefore without any cellular recruit-
ment to this site. Together, these data support a role
for direct mucosal application of AIC as a possible
new form of available immunotherapy for ragweed-
sensitized patients.
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